Sign in →

Test Code RSCOC Coccidioides Antibody Reflex, Complement Fixation and Immunodiffusion, Serum

Reporting Name

Coccidioides Ab, CompF/ImmDiff,S

Specimen Type

Serum


Ordering Guidance


 



Specimen Required


Only orderable as a reflex. For more information see COXIS / Coccidioides Antibody Screen with Reflex, Serum.


Specimen Minimum Volume

1.2 mL

Specimen Stability Information

Specimen Type Temperature Time Special Container
Serum Refrigerated (preferred) 14 days
  Frozen  14 days

Reject Due To

All specimens will be evaluated at Mayo Clinic Laboratories for test suitability.

Reference Values

Only orderable as a reflex. For more information see COXIS / Coccidioides Antibody Screen with Reflex, Serum.

 

COMPLEMENT FIXATION:

Negative

If positive, results are titered.

 

IMMUNODIFFUSION:

Negative

Results are reported as positive, negative, or equivocal.

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Test Classification

This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.

CPT Code Information

86635 x 3

LOINC Code Information

Test ID Test Order Name Order LOINC Value
RSCOC Coccidioides Ab, CompF/ImmDiff,S 26625-4

 

Result ID Test Result Name Result LOINC Value
35942 Coccidioides Ab, CompF,S 33379-9
35943 Coccidioides, IgG, ImmDiff,S 46182-2
35944 Coccidioides, IgM, ImmDiff,S 46183-0

Method Name

Only orderable as a reflex. For more information see COXIS / Coccidioides Antibody Screen with Reflex, Serum.

 

Complement Fixation (CF)/Immunodiffusion (ID)

Useful For

Detection of antibodies to Coccidioides species

Clinical Information

Coccidioidomycosis (valley fever, San Joaquin Valley fever) is a fungal infection found in the Southwestern US, Central America, and South America. It is acquired by inhalation of arthroconidia of Coccidioides immitis/posadasii. Usually, it is a mild, self-limiting pulmonary infection. Less commonly, chronic pneumonia may occur, progressing to fibronodular, cavitary disease. A rash often develops within a day or 2, followed by erythema nodosum or multiforme and accompanying arthralgias. About 2 weeks after exposure, symptomatic patients develop fever, cough, malaise, and anorexia; chest pain is often severe. Coccidioidomycosis may disseminate beyond the lungs to involve multiple organs, including the meninges.

 

IgG antibody is detected by the complement-fixation tests. Precipitating antibodies (IgM and IgG) are detected by immunodiffusion. They are rarely found in cerebrospinal fluid; however, their presence is associated with meningitis. Chronic coccidioidal pulmonary cavities are often accompanied by IgG and IgM precipitating antibodies.

 

Serologic testing for coccidioidomycosis should be considered when patients exhibit symptoms of pulmonary or meningeal infection and have lived or traveled in areas where Coccidioides immitis/posadasii is endemic. Any history of exposure to the organism or travel cannot be overemphasized when a diagnosis of coccidioidomycosis is being considered.

Interpretation

Complement Fixation:

Titer results of 1:2 or higher may suggest active disease; however, titers may persist for months after infection has resolved. Increasing complement fixation (CF) titer results in serial specimens are considered diagnostic of active disease.

 

Immunodiffusion:

The presence of IgM antibody may be detectable within 2 weeks after the onset of symptoms; however, antibody may be detected longer than 6 months after infection.

 

The presence of IgG antibody parallels the CF antibody and may suggest an active or a recent asymptomatic infection with Coccidioides immitis/posadasii; however, antibodies may persist after the infection has resolved.

 

An equivocal result (a band of nonidentity) cannot be interpreted as significant for a specific diagnosis. However, this may be an indication that a patient should be followed serologically.

 

Over 90% of primary symptomatic cases will be detected by combined immunodiffusion (ID) and CF testing.

Day(s) Performed

Monday through Friday

Report Available

4 to 7 days

Specimen Retention Time

14 days